INmune Bio Inc. (INMB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

INmune Bio Inc.

NASDAQ: INMB · Real-Time Price · USD
2.08
-0.06 (-2.80%)
At close: Oct 03, 2025, 3:59 PM
2.08
0.00%
After-hours: Oct 03, 2025, 07:46 PM EDT

INmune Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
20.92M 35.85M 52.15M 74.81M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
79K 131K 99K 99K
Receivables
1.41M 2.44M 8.46M 5.5M
Inventory
n/a n/a 34K -5.5M
Other Current Assets
331K n/a -34K 5.5M
Total Current Assets
22.66M 39.94M 64.67M 82.61M
Property-Plant & Equipment
307K 414K 507K 726K
Goodwill & Intangibles
16.51M 16.51M 16.51M 16.51M
Total Long-Term Assets
16.9M 17.06M 17.12M 17.34M
Total Assets
39.56M 57M 81.8M 99.94M
Account Payables
6.56M 7.9M 5.21M 3.8M
Deferred Revenue
n/a n/a 616K 474K
Short-Term Debt
n/a 9.92M 5M 72K
Other Current Liabilities
517K 524K 9K -62K
Total Current Liabilities
7.22M 18.46M 10.92M 4.36M
Long-Term Debt
n/a n/a 9.7M 14.46M
Other Long-Term Liabilities
n/a n/a 550K 199K
Total Long-Term Liabilities
244K 397K 10.77M 15.36M
Total Liabilities
7.46M 18.86M 21.69M 19.72M
Total Debt
384K 10.44M 15.31M 15.23M
Book Value
32.1M 38.14M 60.1M 80.22M
Book Value Per Share
1.61 2.12 3.35 4.97
Common Stock
22K 817K 18K 18K
Retained Earnings
-163.1M -121.02M -91.01M -63.72M
Comprehensive Income
-575K -799K -699K 1K
Shareholders Equity
32.1M 38.14M 60.1M 80.22M
Total Investments
n/a n/a n/a n/a